| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ALT over the last quarter tilts toward buying: insiders added a net 15,000 shares worth roughly $44K.
Classified under Biotechnology (Health Care sector), ALT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 424.5K | $1.30M | - | |
| Other | 113.7K | $274.5K | - | |
| Other | 70.1K | $215.2K | - | |
| CEO | 62.5K | $184.4K | - | |
| CFO | 49.9K | $137.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2020 | Schafer Klaus | Director | Buy | 2,000 | $11.99 | $23,980.00 | +29.0% | |
| Dec 1, 2020 | Hodges Philip | Director | Sell | 3,727 | $12.51 | $46,613.58 | -100% | |
| Nov 30, 2020 | Gill John | Director | Sell | 8,425 | $11.92 | $100,426.00 | -42.9% | |
| Nov 12, 2020 | Harris Matthew Scott | Director | Sell | 4,015 | $10.02 | $40,230.30 | -49.7% | |
| Nov 12, 2020 | Pisano Wayne67 | Director | Sell | 10,352 | $9.90 | $102,484.80 | -54.9% | |
| Nov 12, 2020 | Schafer Klaus | Director | Sell | 10,150 | $9.91 | $100,586.50 | -59.5% | |
| Jun 15, 2020 | Venrock Healthcare Capital Partners Iii, L.P.54 | 10% Owner | Buy | 1,500,000 | $7.54 | $11,310,000.00 | +50.0% | |
| May 28, 2020 | Venrock Healthcare Capital Partners Iii, L.P.54 | 10% Owner | Buy | 1,303,636 | $8.74 | $11,395,493.13 | +76.8% | |
| May 15, 2020 | Velocity Pharmaceutical Holdings LLC | 10% Owner | Sell | 200,000 | $4.79 | $957,100.48 | -10.6% | |
| Sep 5, 2019 | Garg Vipin K | President and CEO | Buy | 20,000 | $2.10 | $42,000.00 | +6.2% |